1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer

New EMBO Members 2008


EMBO honours 59 leading life scientists


Heidelberg, 15 October 2008 – Fifty-nine leading life scientists from Europe and around the world were today recognised by the European Molecular Biology Organization (EMBO) for their proven excellence in research. Fifty-one of the researchers, distinguished as EMBO Members, are from Europe and neighbouring countries while eight equally respected scientists come from other parts of the world and join as Associate Members, bringing the current membership total to 1360.


Membership is a life-long honour with new members nominated and elected annually by existing members. EMBO Members represent a high-profile cross section of researchers from all fields of molecular life sciences ranging from developmental biology, genomics, molecular medicine, neuroscience and plant biology to systems biology. Forty-eight scientists from the EMBO membership have received the Nobel Prize, many others are recipients of prestigious international awards.


"We welcome this illustrious group of researchers to EMBO membership. Their individual contributions have significantly advanced the molecular life sciences," said Hermann Bujard, EMBO Executive Director. "As EMBO Members, they will participate in the organisation's numerous activities that foster talented scientists to contribute knowledge to address the challenges of a changing world."


The newly elected EMBO Members are active researchers, based in 13 European countries. Associate Members have research groups in Australia, Singapore and the US. This year, nine women scientists are recognised for their significant contributions to life science research. A list of all newly elected EMBO Members and Associate Members accompanies this announcement.


EMBO will welcome this year's newly elected members and associate members at The EMBO Meeting to be held in Amsterdam from 29 August to 1 September 2009.



Name Institute Country
Klaus Aktories University of Freiburg Freiburg, DE
Leif Andersson Uppsala University Uppsala, SE
Peter Angel German Cancer Research Center Heidelberg, DE
Bruno Antonny French National Center for Scientific Research Valbonne, FR
Cecília Arraiano New University of Lisbon Oeiras, PT
Nenad Ban Swiss Federal Institute of Technology Zurich Zürich, CH
Philippe Bastiaens Max Planck Institute for Molecular Physiology Dortmund, DE
Thomas Boller University of Basel, Botanical Institute Basel, CH
Thomas Bourgeron Pasteur Institute Paris, FR
Sarah Bray University of Cambridge Cambridge, UK
James Briscoe National Institute for Medical Research London, UK
Javier Cáceres MRC Human Genetics Unit Edinburgh, UK
Giacomo Cavalli French National Center for Scientific Research Montpellier, FR
Elena Conti Max Planck Institute of Biochemistry Martinsried, DE
Wouter de Laat The Hubrecht Institute Utrecht, NL
Paul Freemont Imperial College London London, UK
Stephen Fuller University of Oxford Oxford, UK
Thierry Gaude ENS Lyon Lyon, FR
Michel Georges The University of Liege Liège, BE
Colin Goding University of Oxford Oxford, UK
Alex Gould MRC National Institute for Medical Research London, UK
Thanos Halazonetis University of Geneva Geneva, CH
Dirk Heinz Helmholtz Centre for Infection Research Braunschweig, DE
Ykä Helariutta University of Helsinki Helsinki, FI
Winship Herr University of Lausanne Lausanne, CH
Heribert Hirt URGV - Plant Genomics Research Unit Evry, FR
Judith Klumperman Utrecht University Utrecht, NL
Pierre Léopold University of Nice Sophia Antipolis, CNRS Nice, FR
Gary Richard Lewin The Max Delbrück Center for Molecular Medicine Berlin, DE
Peter Lichter German Cancer Research Center Heidelberg, DE
Maria Pia Longhese The University of Milan - Bicocca Milano, IT
Andrew Lumsden University of London, MRC London, UK
Gero Miesenböck University of Oxford Oxford, UK
Luigi Naldini Scientific Institute San Raffaele Milano, IT
Manolis Pasparakis University of Cologne Cologne, DE
Daniel Peeper The Netherlands Cancer Institute Amsterdam, NL
Joseph Penninger The Institute of Molecular Biotechnology Vienna, AT
Salomé Prat Spanish National Center of Biotechnology Madrid, ES
Olivier Schwartz Pasteur Institute Paris, FR
Camilla Sjögren Karolinska Institute Stockholm, SE
Len Stephens The Babraham Institute Cambridge, UK
Brigitta Stockinger MRC National Institute for Medical Research London, UK
Markus Stoffel Institute of Molecular Systems Biology Zürich, CH
Tomoyuki Tanaka The University of Dundee Dundee, UK
Mike Tyers The University of Edinburgh Edinburgh, UK
Helle Ulrich Cancer Research UK South Mimms, Herts, UK
Bas van Steensel The Netherlands Cancer Institute Amsterdam, NL
Bart Vanhaesebroeck University of London, Institute of Cancer Research London, UK
Núria Verdaguer Barcelona Institute of Molecular Biology Barcelona, ES
Sinisˇa Volarevic´ The University of Rijeka Rijeka, HR
Roger Williams The Laboratory of Molecular Biology, MRC Cambridge, UK



Name Institute Country
Spyros Artavanis-Tsakonas Harvard Medical School Boston, US
Claude Desplan New York University New York, US
Scott Emr Cornell University Ithaca, US
Ronald N. Germain National Institutes of Health Bethesda, US
Richard Paul Harvey Victor Chang Cardiac Research Institute Darlinghurst , AU
Edison Liu Genome Institute Of Singapore Singapore, SG
Elliot M. Meyerowitz California Institute of Technology Pasadena, US
Thomas Silhavy Princeton University Princeton, US


This email address is being protected from spambots. You need JavaScript enabled to view it.


Tilmann KießlingTilmann Kießling
Head, Communications
T. + 49 160 9019 3839